James Polewaczyk - IDEXX Laboratories Ex Officer
| IX1 Stock | EUR 420.70 3.50 0.83% |
Insider
James Polewaczyk is Ex Officer of IDEXX Laboratories
| Age | 59 |
| Phone | 207 556 0300 |
| Web | https://www.idexx.com |
James Polewaczyk Latest Insider Activity
Tracking and analyzing the buying and selling activities of James Polewaczyk against IDEXX Laboratories stock is an integral part of due diligence when investing in IDEXX Laboratories. James Polewaczyk insider activity provides valuable insight into whether IDEXX Laboratories is net buyers or sellers over its current business cycle. Note, IDEXX Laboratories insiders must abide by specific rules, including filing SEC forms every time they buy or sell IDEXX Laboratories'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
James Polewaczyk over three months ago Disposition of 3290 shares by James Polewaczyk of IDEXX Laboratories at 558.8822 subject to Rule 16b-3 | ||
James Polewaczyk over six months ago Disposition of 680 shares by James Polewaczyk of IDEXX Laboratories at 559.3318 subject to Rule 16b-3 |
IDEXX Laboratories Management Efficiency
The company has return on total asset (ROA) of 0.2167 % which means that it generated a profit of $0.2167 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 1.0458 %, meaning that it generated $1.0458 on every $100 dollars invested by stockholders. IDEXX Laboratories' management efficiency ratios could be used to measure how well IDEXX Laboratories manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Kristine CFA | Westinghouse Air Brake | N/A | |
| Elisa Bressan | Air New Zealand | N/A | |
| Kerstin Timm | Tradegate AG Wertpapierhandelsb | N/A | |
| David DeNinno | Westinghouse Air Brake | 67 | |
| Umut Shayakhmetova | JSC Halyk bank | 54 | |
| John Mastalerz | Westinghouse Air Brake | 56 | |
| Greg Sbrocco | Westinghouse Air Brake | 54 | |
| Aivar Bodanov | JSC Halyk bank | 61 | |
| KlausGerd Kleversaat | Tradegate AG Wertpapierhandelsb | N/A | |
| Dauren Sartayev | JSC Halyk bank | 41 | |
| Roman Maszczyk | JSC Halyk bank | N/A | |
| Rafael Santana | Westinghouse Air Brake | 51 | |
| Eric Gebhardt | Westinghouse Air Brake | 55 | |
| Holger Timm | Tradegate AG Wertpapierhandelsb | N/A | |
| John Olin | Westinghouse Air Brake | 62 | |
| Olga Vuros | JSC Halyk bank | N/A | |
| Nariman Mukushev | JSC Halyk bank | N/A | |
| FRM CFA | JSC Halyk bank | 50 | |
| Yertay Salimov | JSC Halyk bank | 49 | |
| Pascal Schweitzer | Westinghouse Air Brake | 46 | |
| Pavel Cheussov | JSC Halyk bank | N/A | |
Management Performance
| Return On Equity | 1.05 | |||
| Return On Asset | 0.22 |
IDEXX Laboratories Leadership Team
Elected by the shareholders, the IDEXX Laboratories' board of directors comprises two types of representatives: IDEXX Laboratories inside directors who are chosen from within the company, and outside directors, selected externally and held independent of IDEXX. The board's role is to monitor IDEXX Laboratories' management team and ensure that shareholders' interests are well served. IDEXX Laboratories' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, IDEXX Laboratories' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sharon Underberg, Gen VP | ||
| Ken Grady, VP Officer | ||
| Jonathan Mazelsky, CEO Pres | ||
| Nimrata PE, Ex Operations | ||
| Martin Smith, Ex CTO | ||
| James Polewaczyk, Ex Officer | ||
| Michael Lane, Ex Technology | ||
| John Hart, VP Operations | ||
| Jeffery Chadbourne, Director Reporting | ||
| Brian McKeon, Ex CFO |
IDEXX Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is IDEXX Laboratories a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 1.05 | |||
| Return On Asset | 0.22 | |||
| Profit Margin | 0.20 % | |||
| Operating Margin | 0.27 % | |||
| Current Valuation | 35.12 B | |||
| Shares Outstanding | 82.9 M | |||
| Shares Owned By Insiders | 0.39 % | |||
| Shares Owned By Institutions | 92.77 % | |||
| Price To Earning | 57.45 X | |||
| Price To Book | 75.09 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in IDEXX Stock
When determining whether IDEXX Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IDEXX Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Idexx Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Idexx Laboratories Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IDEXX Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.